Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (Nasdaq: JAGX) on September 21, 2026, covering events occurring on September 15, 2026, and September 17, 2026. The filing addresses corporate governance changes regarding preferred stock and a significant capital structure adjustment via a reverse stock split.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate actions rather than financial performance metrics.
Material Changes
- Elimination of Preferred Stock: On September 15, 2026, the Company filed a Certificate of Elimination with the Delaware Secretary of State. This action removed Series B-2 through Series O Preferred Stock from the Company's Certificate of Incorporation. All outstanding shares of these series had been converted, exchanged, or disposed of prior to this date, leaving no shares outstanding immediately before the filing.
- Reverse Stock Split: On September 17, 2026, the Company effected a 1-for-15 reverse stock split of its Common Stock. Following this transaction, the Company reported approximately 520,088 outstanding shares of Common Stock.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies were disclosed in this report, other than the standard incorporation by reference of the full text of the Certificates of Elimination.
Investor Verification Checklist
- Verify the post-split share count of approximately 520,088 shares against subsequent trading data.
- Confirm the current authorized but undesignated preferred stock status following the elimination of Series B-2 through O.
- Review the full text of Exhibit 3.1 (Certificate of Elimination) for any residual rights or conditions attached to the eliminated series.
- Check for any subsequent filings regarding the Company's compliance with Nasdaq listing standards following the reduction in share count.